Anicare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 04-07-2024
- Paid Up Capital ₹ 7.50 M
as on 04-07-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.26 Cr
as on 04-07-2024
- Revenue -1.20%
(FY 2022)
- Profit -14.21%
(FY 2022)
- Ebitda -20.11%
(FY 2022)
- Net Worth 16.59%
(FY 2022)
- Total Assets 14.85%
(FY 2022)
About Anicare Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹8.26 Cr.
Hitesh Mehta, Amit Mehta, and Manisha Mehta serve as directors at the Company.
- CIN/LLPIN
U51397MH1994PTC081420
- Company No.
081420
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Anicare Pharmaceuticals Private Limited offer?
Anicare Pharmaceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Care Cosmetics, Hair Oil, Herbal Hair Oil, Hair Care Products, Child and Baby Care Products, Baby Care Products, Body Scrubs, Hair Conditioner, Business Planning and Management.
Who are the key members and board of directors at Anicare Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Mehta  | Director | 23-Sep-1994 | Current |
| Amit Mehta | Whole-Time Director | 23-Sep-1994 | Current |
| Manisha Mehta | Whole-Time Director | 23-Sep-1994 | Current |
Financial Performance of Anicare Pharmaceuticals.
Anicare Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.2% decrease. The company also saw a substantial fall in profitability, with a 14.21% decrease in profit. The company's net worth Soared by an impressive increase of 16.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anicare Pharmaceuticals?
In 2020, Anicare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 20 Jun 2013 | ₹3.70 M | Open |
Bank Of India Creation Date: 20 Sep 2010 | ₹4.00 M | Open |
Bank Of India Creation Date: 22 Aug 2008 | ₹2.54 Cr | Open |
How Many Employees Work at Anicare Pharmaceuticals?
Anicare Pharmaceuticals has a workforce of 26 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anicare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anicare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
